Cargando…
Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer
INTRODUCTION: Programmed death-ligand 1 (PD-L1) expression as measured by immunohistochemistry (IHC) has been employed to predict the efficacy of anti-PD-1/PD-L1 therapy. Nevertheless, heterogeneous PD-L1 expression represents a challenge for the selection of patients for anti-PD-1/PD-L1 therapy. ME...
Autores principales: | Xu, Haipeng, Chen, Xueyan, Lin, Dong, Zhang, Jing, Li, Chao, Zhang, Dianbao, Zhang, Xianfen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941607/ https://www.ncbi.nlm.nih.gov/pubmed/31920342 http://dx.doi.org/10.2147/OTT.S223643 |
Ejemplares similares
-
Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review
por: Zhang, Dianbao, et al.
Publicado: (2016) -
Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells
por: Zhang, Dianbao, et al.
Publicado: (2023) -
Imaging in cervical nodal metastases of unknown primary
por: Hermans, Robert
Publicado: (2011) -
Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer
por: Tarabichi, M, et al.
Publicado: (2015) -
The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer
por: Sopik, Victoria, et al.
Publicado: (2018)